Cytokine quantification.

ZH Zhengping Huang
KB Kailey E. Brodeur
LC Liang Chen
D Du
HW Holly Wobma
EH Evan E. Hsu
ML Meng Liu
JC Joyce C. Chang
MC Margaret H. Chang
JC Janet Chou
MD Megan Day-Lewis
FD Fatma Dedeoglu
OH Olha Halyabar
JL James A. Lederer
TL Tianwang Li
ML Mindy S. Lo
ML Meiping Lu
EM Esra Meidan
JN Jane W. Newburger
AR Adrienne G. Randolph
MS Mary Beth Son
RS Robert P. Sundel
MT Maria L. Taylor
HW Huaxiang Wu
QZ Qing Zhou
SC Scott W. Canna
KW Kevin Wei
LH Lauren A. Henderson
PN Peter A. Nigrovic
PL Pui Y. Lee
request Request a Protocol
ask Ask a question
Favorite

Plasma IL-18 and CXCL9 were measured by ELISA as previously described (15). Plasma IL-15 was quantified by proximity extension assay through Olink. Bioactivity of IFN-I in human plasma was measured using a luciferase reporter cell line as described (67). HEK 293T cells with luciferase expression under the control of IFN-sensitive response element were maintained in DMEM supplemented with penicillin / streptomycin and 10% FBS. Cells (1 × 105 per well) were plated in a 96-well plate and cultured in 200 μL of complete medium with 10% human plasma (from healthy controls or patients) for 18 hours. Duplicate wells were tested for each plasma sample. Cell lysate preparation and quantification of luciferase activity were performed using the BrightGlo reagent (Promega) according to manufacturer’s instructions.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A